Skip to main content
Premium Trial:

Request an Annual Quote

Thorne HealthTech, GenTegra Partner on Whole-Blood DNA Collection Kit

NEW YORK — Thorne HealthTech said on Tuesday that it has partnered with sample prep firm GenTegra to develop a whole-blood DNA collection and extraction kit.

Under the terms of the alliance, the kit will integrate Thorne's OneDraw blood collection device, developed by Drawbridge Health, with GenTegra's Active Chemical Protection, which is designed to keep nucleic acid and other biomolecules stable in a dry ambient state.

Financial and other terms were not disclosed.

The OneDraw device has been cleared by Japan's Pharmaceutical and Medical Devices Agency, is CE marked for use in A1c testing, and is cleared by the US Food and Drug Administration. Drawbridge is majority owned by Summerville, South Carolina-based Thorne.

"GenTegra's Active Chemical Protection technology is utilized across a broad range of life science applications to stabilize and protect DNA and RNA from a variety of sample types," GenTegra President Bob Barrett said in a statement. "We're encouraged by the progress and successes we've been testing and are looking forward to working with Thorne and its OneDraw device and cartridge to further enhance DNA preservation and extraction for remote patient sample collection."

Thorne said that it intends to collaborate further with Pleasanton, California-based GenTegra to develop a product that combines OneDraw DNA cartridges with GenTegra's GenSolve DNA extraction technology.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.